Antibodies to myelin basic protein, myelin oligodendrocytes peptides, α-β-crystallin, lymphocyte activation and cytokine production in patients with multiple sclerosis

Journal of Internal Medicine

Volumn 254, Issue 4, 2003, Pages 363-374

  Vojdani, Aristo ^a,b,d   Vojdani, E ^c   Cooper, E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Immunosciences Laboratories Inc   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NONE   (United States)

Author keywords

Antibody; Cytokine production; Lymphocyte proliferation; Multiple sclerosis

Indexed keywords

ALPHA CRYSTALLIN; ANTIBODY; BETA CRYSTALLIN; BIOLOGICAL MARKER; CYTOKINE; GAMMA INTERFERON; HEAT SHOCK PROTEIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LYMPHOTOXIN; MYELIN PROTEIN; PEPTIDE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIBODY DETECTION; ARTICLE; BLAST TRANSFORMATION; BLOOD SAMPLING; CELL ISOLATION; CELL SPECIFICITY; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMORAL IMMUNITY; IMMUNOGLOBULIN BLOOD LEVEL; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIA; PARAMETER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; SERUM; T LYMPHOCYTE;

ADULT; ALPHA-CRYSTALLIN B CHAIN; ANTIBODIES; CENTRAL NERVOUS SYSTEM; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; SENSITIVITY AND SPECIFICITY; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0141527582     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2003.01203.x     Document Type: Article

References (45)

1. Noronha A, Arnanson B. Demyelinating diseases. In: Rich RR, Fleisher TA, Schwartz BD, Shearer WT and Strober W. eds. Clinical Immunology. St Louis: Mosby, 1995; 1364-75.
2. Steinman L. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 1996; 85: 299-302.
3. Amor S, Baker D, Layward L, McCormack K, Van Noort JM. Multiple sclerosis: variations on a theme. Immunol Today 1997; 18: 368-71.
4. Raine CS, Cannella B, Hauser SL, Genain CP. Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation. Ann Neurol 1999; 46: 144-60.
5. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BJ. Multiple sclerosis. a review. New Engl J Med 2000; 343: 938-52.
6. Moktarian F, Zhang Z, Shi Y, Gonzales E, Sobel RA. Molecular mimicry between a viral peptide and a myelin oligodendrocyte glycoprotein peptide induces autoimmune demyelinating disease in mice. J Neuroimmunol 1999; 95: 43-8.
7. Esposito M, Venkatesh V, Otvos L et al. Human transaldolase and cross-reactive viral epitopes identified by autoantibodies of multiple sclerosis patients. J Immunol 1999; 163: 4027-32.
8. Genain CP, Cannella B, Hauser SL, Raine CS. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nature Med 1999; 5: 170-75.
9. Holz A, Bielekova B, Martin R, Oldstone MBA. Myelin-associated oligodendrocytic basic protein: Identification of an encephalitogenic epitope and association with multiple sclerosis. J Immunol 2000; 164: 1103-09.
10. Stefferl A, Schubart A, Storch M et al. Butrophilin, a milk protein, modulates the encephafitogenic T-cell response to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis. J Immunol 2000; 165: 2859-65.
11. Bajramovic JJ, Plomp AC, Van Der Goes A et al. Presentation of α-β-crystallin to T-cells in active multiple sclerosis lesions: an early event following inflammatory demyelination. J Immunol 2000; 164: 4359-66.
12. Brock HPM, Uccelli A, Kerlero de Rosbo N et al. Myelin/ oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis in common marmosets: the encephalitogenic T-cell epitope P-MOG 24-36 is presented by a monomorphic MHC class II molecule. J Immunol 2000; 165: 1093-101.
13. Von Büdingen H, Tanuman N, Villaslada P, Ouallet J, Hauser SL, Genain CP. Immune response against the myelin/oligodendrocyte glycoprotein in experimental autoimmune demyelination. J Clin Immunol 2001; 21: 155-60.
14. Chou YK, Bourdette DN. Offner H et al. Frequency of T-cells specific for myelin basic protein and myelin proteolipid protein in blood and cerebrospinal fluid in multiple sclerosis. J Neuroimmunol 1992; 38: 105.
15. Kerlero de Rosbo NR, Milo R, Lees MB, Bureer D, Bernard CC, Ben-Nun A. Reactivity to myelin antigens in multiple sclerosis: peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein. J Clin Invest 1993; 92: 2602.
16. Genain CP, Lee-Parritz D, Nguyen MH, et al. In healthy primates, circulating autoreactive T-cells mediate autoimmune disease. J Clin Invest 1994; 94: 1339-45.
17. Correale JM, McMillan M, McCarthy K, Le T, Weiner LP. Isolation and characterization of autoreactive proteolipid protein-peptide specific T-cell clones from multiple sclerosis patients. Neurology 1995; 45: 1370-76.
18. 't Hart BA, VanMeurs M, Brock HPM et al. A new primate model for multiple sclerosis in the common marmoset. Immunol Today 2000; 21: 290-96.
19. Sadatipour BT, Greer JM, Pender MP. Increased circulating antiganglioside antibodies in primary and secondary progressive multiple scelrosis. Ann Neurol 1998; 44: 980-87.
20. Grogan JL, Kramer A, Nogai A et al. Cross-reactivity of myelin basic protein-specific T-cells with multiple microbial peptides: Experimental autoimmune encephalomyelitis induction in TCR transgenic mice. J Immunol 1999; 163: 3764-70.
21. Xiao B, Link H. Is there a balance between microglia and astrocytes in regulating Th1/Th2-cell responses and neuropathologies? Immunol Today 1999; 20: 477-79.
22. Singh RK, Zang YCQ, Shrivasta A et al. Th-1 and Th-2 deviation of myelin-autoreactive T-cells by altered peptide ligands is associated with reciprocal regulation of Lck, Fyn, and ZAP-70. J Immunol 1999; 163: 6393-402.
23. Hellings N, Baree M, Verhoeven C et al. T-cells reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls. J Neurosci Res 2001; 63: 290-98.
24. + T-cells for the development of experimental autoimmune encephalomyelitis (EAE). J Autoimm 2001; 17: 17-25.
25. Kuchroo VK, Anderson AC, Waldner H, Munder M, Bettelli E, Nicholson LB. T-cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T-cell repertoire. Annu Rev Immunol 2002; 20: 101-09.
26. Koehler NKU, Genain CP, Giesser B, Hauser SL. The human T-cell response to myelin oligodendrocyte glycoprotein: a multiple sclerosis family-based study. J Immunol 2002; 168: 5920-27.
27. Correale J, Gilmore W, McMillan M et al. Patterns of cytokine secretions by autoreactive proteolipid protein-specific T-cell clones during the course of multiple sclerosis. J Immunol 1995; 154: 2959.
28. Navikas V, He B. Link J et al. Augmented expression of tumour necrosis factor-α and lymphotoxin in mononuclear cells in multiple sclerosis and optic neuritis. Brain 1996; 119: 213-18.
29. Hermans GP, Stinissen GP, Hauben L., Van Den Berg-Loonen E, Raus J, Zhang J. Cytokine profile of myelin basic protein-reactive T-cells in multiple sclerosis and healthy individuals. Ann Neurol 1997; 42: 18-23.
30. van Oosten BW, Brakhof F, Scholten PE, Von Blomberg BM, Ader HJ, Polman CH. Increased production of tumor necrosis factor-α and not of interferon-γ, preceding disease activity in patients with multiple sclerosis. Arch Neurol 1998; 55: 793-99.
31. Tejada-Simon MV, Hong J, Rivera VM, Zhang JZ. Reactivity pattern and cytokine profile of T-cells primed by myelin peptides in multiple sclerosis and healthy individuals. Eur J Immunol 2001; 31: 907-17.
32. Poser CM, Paty DW, Scheinberg L et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-31.
33. Miller DH, Grossman RI, Reingold SC. The role of magnetic resonance techniques in understanding and managing multiple sclerosis. Brain 1998; 121: 3-24.
34. Cole SR, Beck RW, Moke PS, Kaufman DI, Tourtellotte WW. The predictive value of CSF oligoclonal banding for MS 5 years after optic neuritis. Neurology 1998; 51: 885-87.
35. Gronseth GS, Ashman EJ. Practice parameter: the usefulness of evoked potentials in identifying clinically silent lesions in patients with suspected multiple sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000; 54: 1720-25.
36. Korogi Y, Takahashi M, Shinzato J, Okajima J. MR findings in seven patients with organic mercury poisoning (Minamata disease) AJNR 1994; 15: 1575-78.
37. Hadjivassiliou M, Grünewald RA, Lawden M, Davies-Jones GAB, Powell T, Smith CML. Headache and CNS white matter abnormalities related with gluten sensitivity. Neurology 2001; 56: 385-88.
38. Hadjivassiliou M, Boscolos S, Davies-Jones GAB et al. The humoral response in the pathogenesis of gluten ataxia. Neurology 2002; 58: 1221-26.
39. Wucherpfenning KW. Infectious triggers for inflammatory neurological diseases. Nature Med 2002; 8: 455-57.
40. Levin MC, Lee SM, Klaume F et al. Autoimmunity due to molecular mimicry as a cause of neurological disease. Nature Med 2002; 8: 509-13.
41. Martin R, Gran B, Zhao Y et al. Molecular mimicry and antigen-specific T-cell responses in multiple sclerosis and chronic CNS Lyme disease. J Autoimm 2001; 16: 187-92.
42. Storch MK, Piddlesden S. Multiple sclerosis: in situ evidence for antibody and complement-mediated demyelination. Ann Neurol 1998; 43: 465-71.
43. Cross AH, Trotter JL, Lyons JA. B-cells and antibodies in CNS demyelinating disease. J Neuroimmunol 2001; 112: 1-14.
44. Challoner PB, Smith KT, Parker JD. Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci USA 1995; 92: 7440-44.
45. Vojdani A, Campbell AW, Anyanwu E, Kashanian A, Bock K, Vojdani E. Antibodies to neuron-specific antigens in children with autism: possible cross-reaction with encephalitogenic proteins from milk, Chlamydia pneumoniae and Streptococcus group A. J Neuroimmunol 2002; 129: 168-77.